Roche Diagnostics Corporation Cell Marque, Cytokeratin 19

Roche Diagnostics Corporation cell marque, cytokeratin 19; anti-cytokeratin 19 reacts with a wide variety of epithelium and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver and breast. perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although, follicular carcinoma is also labeled by this antibody approximately 5-6% of the time. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)